"10.1371_journal.pgen.1003846","plos genetics","2013-10-03T00:00:00Z","Elisa Degenkolbe; Jana K√∂nig; Julia Zimmer; Maria Walther; Carsten Rei√üner; Joachim Nickel; Frank Pl√∂ger; Jelena Raspopovic; James Sharpe; Katarina Dathe; Jacqueline T Hecht; Stefan Mundlos; Sandra C Doelken; Petra Seemann","Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Charit√© ‚Ä Universit√§tsmedizin Berlin, Berlin, Germany; Berlin-Brandenburg School for Regenerative Therapies (BSRT), Charit√© ‚Ä Universit√§tsmedizin Berlin, Berlin, Germany; Institute of Anatomy, Dept. Anatomy and Molecular Neurobiology, Universit√§tsklinikum M√ºnster, M√ºnster, Germany; Lehrstuhl f√ºr Physiologische Chemie II, Theodor-Boveri-Institut f√ºr Biowissenschaften (Biozentrum) der Universit√§t W√ºrzburg, W√ºrzburg, Germany; Department of Tissue Engineering and Regenerative Medicine, Universit√§tsklinikum W√ºrzburg, W√ºrzburg, Germany; Biopharm GmbH, Heidelberg, Germany; EMBL-CRG Systems Biology Program, Centre for Genomic Regulation, Barcelona, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; Instituci√≥ Catalana de Recerca i Estudis Avan√ßats (ICREA), Barcelona, Spain; Institut f√ºr Medizinische Genetik und Humangenetik, Charit√© ‚Ä Universit√§tsmedizin Berlin, Berlin, Germany; Department of Pediatrics, University of Texas Medical School at Houston, Houston, Texas, United States of America; Research Group Development and Disease, Max Planck Institute for Molecular Genetics, Berlin, Germany","Conceived and designed the experiments: PS. Performed the experiments: ED JK JZ MW JN JR. Analyzed the data: ED JK JZ MW CR JN FP JR JS KD JTH SM SCD PS. Contributed reagents/materials/analysis tools: CR JN FP JS JTH SM SCD PS. Wrote the paper: ED PS.","Frank Pl√∂ger is an employee of the company Biopharm GmbH as indicated in the affiliation. Biopharm GmbH is a 100% privately owned company. All other authors have declared that no competing interests exist.","2013","10","Elisa Degenkolbe","ED",14,FALSE,1,6,14,2,TRUE,TRUE,FALSE,0,NA,FALSE
